Home > Income Statement > GUJARAT THEMIS BIOSYN

GUJARAT THEMIS BIOSYN
Revenue

    Back to Income Statement
GUJARAT THEMIS BIOSYN is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for GUJARAT THEMIS BIOSYN
Please provide your vote to see the results

GUJARAT THEMIS BIOSYN Last 5 Year Revenue History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹151 Cr₹170 Cr₹148 Cr₹115 Cr₹91 Cr

What is the latest Revenue of GUJARAT THEMIS BIOSYN ?

The latest Revenue ratio of GUJARAT THEMIS BIOSYN is ₹151 Cr based on Mar2025 Standalone results.
Year Revenue
Mar2025₹151 Cr
Mar2024₹170 Cr
Mar2023₹148 Cr
Mar2022₹115 Cr
Mar2021₹91 Cr

How is Revenue of GUJARAT THEMIS BIOSYN Trending?

Years Revenue % Change
Mar2025 ₹151 Cr
-11.20
Mar2024 ₹170 Cr
14.45
Mar2023 ₹148 Cr
29.19
Mar2022 ₹115 Cr
26.82
Mar2021 ₹91 Cr -

Compare Revenue of peers of GUJARAT THEMIS BIOSYN

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GUJARAT THEMIS BIOSYN ₹3,926.7 Cr 7.8% 31% 2.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹388,680.0 Cr -2.9% -8.9% -3.7% Stock Analytics
DIVIS LABORATORIES ₹168,817.0 Cr 1.2% 4.2% 8.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹139,297.0 Cr -1.7% -3.6% 27.4% Stock Analytics
DR REDDYS LABORATORIES ₹109,828.0 Cr 6.8% 1.3% 13.2% Stock Analytics
CIPLA ₹104,588.0 Cr 5.4% 3.1% -13.6% Stock Analytics


GUJARAT THEMIS BIOSYN Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GUJARAT THEMIS BIOSYN

7.8%

31%

2.4%

SENSEX

-2.3%

3.3%

-2.4%


You may also like the below Video Courses